Detalhe da pesquisa
1.
Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults.
J Infect Dis
; 225(11): 1915-1922, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34962997
2.
The Impact of the COVID-19 Pandemic on the Incidence of Herpes Zoster: A Narrative Literature Review.
Infect Dis Ther
; 13(3): 447-461, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38441844
3.
Increased Risk of Herpes Zoster in Adults ≥50 Years Old Diagnosed With COVID-19 in the United States.
Open Forum Infect Dis
; 9(5): ofac118, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35392454
4.
A practitioner's guide to the recombinant zoster vaccine: review of national vaccination recommendations.
Expert Rev Vaccines
; 20(9): 1065-1075, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34311643
5.
Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults.
Appl Health Econ Health Policy
; 17(5): 723-732, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31250218
6.
The comparative efficacy and safety of herpes zoster vaccines: A network meta-analysis.
Vaccine
; 37(22): 2896-2909, 2019 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30982636
7.
Transcriptional inhibition of interleukin-12 promoter activity in Leishmania spp.-infected macrophages.
J Parasitol
; 94(1): 84-93, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18372625